Why Moderna is Rebranding Its Cancer Vaccine as “Therapy”
Moderna is rebranding its mRNA cancer breakthroughs as “individualized neoantigen therapy” (INT) to bypass vaccine skepticism fueled by the U.S. Government. By shifting terminology from “vaccine” to “therapy,” the biotech ... Read More